Geriatric intervention for frail patients with advanced GI cancers receiving palliative chemotherapy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on elderly patients aged 65 and older who have metastatic or unresectable gastric, biliary, and pancreatic cancers. It aims to assess the impact of frailty intervention measures on the outcomes of these patients receiving palliative chemotherapy. The study addresses the challenges faced by elderly patients, including concerns about treatment toxicity and comorbidities, which often lead to under-treatment. By implementing a comprehensive geriatric assessment, the study seeks to optimize chemotherapy administration and improve quality of life for this vulnerable population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients aged sixty-five or older with metastatic or unresectable gastric, biliary, and pancreatic cancer.
* The patient must sign the informed consent form.
* Estimated survival period of more than 3 months.
* Conscious and able to communicate verbally or in writing, and willing to cooperate with invasive procedures.

Exclusion Criteria:

* Patients with cognitive impairment or unable to cooperate with the interventional procedures as determined by the clinical physician.
* Patients receiving concurrent other anticancer treatments (radiation or surgery).
* Patients with multiple types of cancer requiring simultaneous treatment.
* Patients who have previously participated in this study during a prior chemotherapy regimen.

Where it's running

• Chang Gung Memorial Hospital
  Taoyuan, Taiwan, Taiwan Recruiting

Study contacts

• Study coordinator: Wen-Chi Chou, M.D.
• Email: f12986@cgmh.org.tw
• Phone: +886328-1200

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Gustabor: Tailored AI Nutrition for Taste Changes During Cancer Therapy

  This trial tests whether personalized, AI-assisted dietary advice helps people with taste changes from cancer treatment compare to general dietary guidance.

  Recruiting at 2 sites Wuerzburg University Hospital · Augsburg, Bavaria and 5 other locations · NCT07649681

• AI-based nutrition plan to help with taste changes during cancer treatment

  A personalized AI-assisted nutrition plan is tested to see if it helps people with cancer-related taste changes.

  Recruiting at 2 sites Wuerzburg University Hospital · Munich, Bavaria and 2 other locations · NCT07040189

• Long-term outcomes of endoscopic procedures for upper gastrointestinal cancers

  This study looks at how well certain endoscopic procedures work for treating larger upper gastrointestinal cancers and what the long-term results are for patients.

  Recruiting Western Sydney Local Health District · Sydney, New South Wales · NCT05804331

• Evaluating Proton Therapy for Tumors Previously Treated with Radiation

  This study is testing a new type of radiation therapy called proton therapy to see if it can help people with tumors that have already been treated with radiation, while causing less harm to healthy tissues.

  Recruiting The New York Proton Center · New York, New York · NCT05313191

• Understanding cancer through genomic profiling and analytics

  This study is trying to understand the genetic features of different types of cancer in people from a community healthcare system to improve screening and treatment options.

  Recruiting at 6 sites Avera McKennan Hospital & University Health Center · Marshall, Minnesota and 5 other locations · NCT05142033

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.